Research Output per year
Personal profile
Keywords
- 317 Pharmacy
International and National Collaboration
Publications and projects within past five years.
Publications 2007 2019
New tricks of prolyl oligopeptidase inhibitors - A common drug therapy for several neurodegenerative diseases
Svarcbahs, R., Julku, U., Kilpelainen, T., Kyyrö, M., Jäntti, M. & Myohänen, T. T., Mar 2019, In : Biochemical Pharmacology. 161, p. 113-120 8 p.Research output: Contribution to journal › Review Article › Scientific › peer-review
Constitutive Ret signaling leads to long-lasting expression of amphetamine-induced place conditioning via elevation of mesolimbic dopamine
Kopra, J., Villarta-Aguilera, M., Savolainen, M., Weingerl, S., Myohänen, T. T., Rannanpää, S., Salvatore, M. E., Andressoo, J-O. & Piepponen, T. P., Jan 2018, In : Neuropharmacology. 128, p. 221-230 10 p.Research output: Contribution to journal › Article › Scientific › peer-review
Prolyl Oligopeptidase Regulates Dopamine Transporter Phosphorylation in the Nigrostriatal Pathway of Mouse
Julku, U. H., Panhelainen, A. E., Tiilikainen, S. E., Svarcbahs, R., Tammimäki, A. E., Piepponen, T. P., Savolainen, M. H. & Myöhänen, T. T., Jan 2018, In : Molecular Neurobiology. 55, 1, p. 470-482 13 p.Research output: Contribution to journal › Article › Scientific › peer-review
Open Access
File
Removal of prolyl oligopeptidase reduces alpha-synuclein toxicity in cells and in vivo
Svarcbahs, R., Julku, U. H., Norrbacka, S. & Myöhänen, T. T., 2018, In : Scientific Reports. 8, 1, 18 p., 1552.Research output: Contribution to journal › Article › Scientific › peer-review
Open Access
File
Nigral injection of a proteasomal inhibitor, lactacystin, induces widespread glial cell activation and shows various phenotypes of Parkinson's disease in young and adult mouse
Savolainen, M. H., Albert, K., Airavaara, M. & Myohänen, T. T., Jul 2017, In : Experimental Brain Research. 235, 7, p. 2189-2202 14 p.Research output: Contribution to journal › Article › Scientific › peer-review
Projects 2010 2022
Prolyylioligopeptidaasi (PREP) - mahdollinen biomarkkeri ja yhteinen lääkekehityskohde useaan hermostoa rappeuttavaan sairauteen?
Myöhänen, T. & Kilpeläinen, T.
01/09/2018 → 31/08/2022
Project: Research project
Prolyylioligopeptidaasin ligandit - yhteinen hoitomuoto useille hermostoa rappeuttaville sairauksille?
01/10/2016 → 30/09/2018
Project: Research project
The effects of Prolyl Oligopeptidase (POP) and its inhibition on alpha-synuclein aggregation and Parkinson's disease
Myöhänen, T., Savolainen, M. & Svarcbahs, R.
01/09/2013 → 31/08/2018
Project: Research project
Uusia hoitomahdollisuuksia Parkinsonin tautiin? - Prolyylioligopeptidaasi ja sen estäminen
01/01/2011 → 31/07/2013
Project: Research project
Prizes
Activities 2009 2019
Prolyl oligopeptidase on alpha-synuclein aggregation
Timo Myöhänen (Speaker)26 Feb 2019
Activity: Talk or presentation types › Invited talk
World Congress on Basic and Clinical Pharmacology 2018
Timo Myöhänen (Attendee)5 Jul 2018
Activity: Participating in or organising an event types › Organisation and participation in conferences, workshops, courses, seminars
Epilepsia Open (Journal)
Timo Myöhänen (Reviewer)2018
Activity: Publication peer-review and editorial work types › Peer review of manuscripts
Journal of Neuroinflammation (Journal)
Timo Myöhänen (Reviewer)2018
Activity: Publication peer-review and editorial work types › Peer review of manuscripts
Neurochemistry International (Journal)
Timo Myöhänen (Reviewer)2018
Activity: Publication peer-review and editorial work types › Peer review of manuscripts
Press / Media
Edistysaskelia Parkinsonin taudin hoidossa
28/04/2017
1 item of media coverage
Press/Media: Press / Media
Isoja harppauksia Parkinson-potilaiden hoidossa
01/04/2017
1 media contribution
Press/Media: Press / Media
Finnish researchers correct Parkinson's motor symptoms in mice
15/12/2016 → 20/12/2016
4 items of media coverage
Press/Media: Press / Media
Suomalaistutkijat korjasivat hiireltä Parkinsonin taudin liikehäiriöt
08/01/2016 → 09/12/2016
8 items of media coverage
Press/Media: Press / Media